D.-L. Li, Z.-L. Wei, W.-M. Zhang, and Z.-G. Li, “Anti-tumor activity of cabozantinib by FAK down-regulation in human oral squamous cell carcinoma”, Bangladesh J Pharmacol, vol. 11, no. 1, pp. 119–125, Dec. 2015.